Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The O-antigen polysaccharide is a key surface component of extraintestinal pathogenic Escherichia coli (ExPEC), which are strains of E. coli responsible for infections outside the intestinal tract. The O-antigen forms the outermost part of the lipopolysaccharide (LPS) layer on the bacterial outer membrane and is composed of repeating oligosaccharide units that vary in structure among different serotypes. It protects ExPEC from host immune defenses and is a critical role in immune evasion and virulence. As a major surface antigen, the O-antigen is an attractive target for multivalent vaccines. Genes responsible for synthesis are organized into clusters typically located between galF and gnd loci on the chromosome.
Opsonophagocytic killing (via elicited antibodies)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extraintestinal Pathogenic Escherichia coli O-antigen Polysaccharide (ExPEC O-antigen).